Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
Autor: | Andre C. Vogel, Nicholas Alakel, Farrah J. Mateen, Shawheen J. Rezaei, Aditya Ravi Kumar, Brittany Gazdag |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
2019-20 coronavirus outbreak medicine.medical_specialty Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunology Neuroimmunology Clinical Neurology Article Neurologist Unmet needs 03 medical and health sciences 0302 clinical medicine Health care Pandemic Immunology and Allergy Medicine Health behavior Neuromyelitis optica business.industry Covid19 medicine.disease 030104 developmental biology Neurology Family medicine Neurology (clinical) Survey instrument business 030217 neurology & neurosurgery Immunosuppression |
Zdroj: | Journal of Neuroimmunology |
ISSN: | 1872-8421 0165-5728 |
Popis: | Purpose This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. Principal results 92% of responding neurologists considered their NMO patients to be at an elevated risk of acquiring Covid19. They also indicated sharp declines in visits, delays in treatment and related services, and several unmet needs deterring treatment. Major conclusions There is a need for evidence-based, comprehensive guidelines for treating NMO patients amid healthcare crises moving forward. Graphical abstract Unlabelled Image Highlights • We surveyed 192 U.S. and Canadian neurologists who treat NMO patients on their experiences with Covid19 in April 2020. • 17% of neurologists have deferred >1 doses of immunosuppressant and 16% have changed the dosing interval • Most neurologists are aware of NMO patients delaying MRIs (57%), clinical visits (67%), and lab testing (52%) |
Databáze: | OpenAIRE |
Externí odkaz: |